Skyscape Web Viewer : Cancer Pharmacology: An Illustrated Manual of Anticancer Drugs : Image Index

View All
Prophylactic Vaccines Stimulate the Immune System Against a Disease Not Yet Experienced by the Host
Proteasome Inhibitors (PIs) Can Be Viewed as the Stoppers for the Waste Disposers of the Cells
Relative Affinities of Folate Receptor (FR) and Reduced Folate Carrier (RFC)
Ribonucleotide Reductase (RNR) is Responsible for Synthesizing Deoxyribonucleotides
Schematic Structure of Gonadotropin-Releasing Hormone (GnRH) Agonist Relative to Native GnRH
Selective Estrogen Receptor Degrader (SERD)
Selective Estrogen Receptor Modulators
Some Anti-MM Drugs with Prominent Activities Mediated Via Discrete Subcellular Organelles
Sources of and rogens in the Human Prostate
Steroid Biosynthesis Aromatase Enzyme
Structures of Antiestrogenic Molecules
Studies Contributing to Dose Refinement
Targeted Cancer Therapies
Targeting the ATR-CHK1-WEE1 Pathway to Inhibit the Replication Checkpoint
Targeting the DNA Damage Response Pathway
Targets for Cancer Drugs
The B-Cell Receptor (BCR) and Bruton Tyrosine Kinase (BTK)
The First Approved Immune Checkpoint Inhibitors Restore Anti-Tumor Immunity
The Flow of Biomarker Identification, Validation, and Application
The Pharmacological Audit Trial (PhAT)
The Probability of Overall Survival in the Two Groups Calculated with the Use of the Kaplan-Meier Method
Therapeutic Activation of Apoptosis
Triazines (Three Attached Nitrogen Atoms)
Tumors Orchestrate a Complex Signaling Network to Evade Immune Destruction
Tumor Stem Cells and Their Microenvironment
Tyrosine Kinase Inhibitors (TKI)
Urinary Excretion of High-Dose Methotrexate (MTX) and Effect of Medications and Urine pH
Vascular Endothelial Growth Factor (VEGF) Receptor
When Functioning Normally, CD8+ T Effector Cells Can Recognize and Destroy Tumor Cells